Workflow
Activity results of 12 months of the year 2025
Globenewswire· 2026-02-27 14:24
Virgilijus Motiejūnas Chief Financial Officer, email: v.motiejunas@kaunoenergija.lt Attachment Financial statements 31.12.2025 EBITDA of 12 months of the year 2025 is as follows: Company's – EUR 27,919 thousand (in 12 months of the year 2024 it was EUR 16,712 thousand), Group's – EUR 28,279 thousand (in 12 months of the year 2024 it was EUR 17,050 thousand). We hereby present the non-audited interim financial statements for the 12 months of the year 2025 together with Confirmation from responsible persons. ...
Coherent's CEO and CFO to Participate in Fireside Chat at Morgan Stanley 2026 TMT Conference on March 3, 2026
Globenewswire· 2026-02-27 14:20
SAXONBURG, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced that the company's CEO Jim Anderson and CFO Sherri Luther will participate in a fireside chat at the Morgan Stanley 2026 Technology, Media & Telecom Conference in San Francisco on Tuesday, March 3, 2026 at 2:35 p.m. PST. A live and recorded audio webcast of the fireside chat will be publicly available via a webcast link posted in the investor relations section of Coherent's website at ...
SEALSQ Expands Japanese Footprint and Announces Key Local Event Participations in March to Showcase PQC Leadership, Aligning with Japan Government's 2035 Quantum Security Mandate
Globenewswire· 2026-02-27 14:15
Core Insights - SEALSQ Corp is strategically participating in events in Japan to support the government's timeline for quantum security transitions, targeting full adoption of post-quantum cryptography (PQC) by 2035 [3][6] - The company is showcasing its hardware-anchored security innovations, including the QS7001 secure SoC and QVault TPM, to facilitate migrations for critical infrastructure and private sectors [3][4] Participation in Key Events - SEALSQ will engage in the Connectivity Standards Alliance (CSA) Member Meeting in Yokohama from March 16-19, 2026, and the Wi-SUN Open House in Tokyo on March 27, 2026 [4] - These events will allow SEALSQ to advance discussions on PQC integrations and showcase its VaultIC secure elements for IoT compliance [5] Strategic Partnerships and Market Momentum - SEALSQ's expansion in Japan is bolstered by partnerships, notably with Okaya Electronics Corp, leading to significant project wins [6] - Collaborations include securing Japan's first Matter-compatible smart lock with MIWA Lock Co., Ltd. and enhancing smart meter security through a partnership with Landis+Gyr [7][8] Celebrating Achievements - SEALSQ will host a private gathering at the Suzuka Japanese Grand Prix from March 27-29, 2026, to celebrate its achievements in Japan [9] - The company is also the official quantum technology partner of the BWT Alpine Formula One Racing Team, exploring quantum-secure applications in high-performance environments [9][10] Technological Advancements - SEALSQ's PQC solutions comply with NIST and CNSA 2.0 standards, providing strong protection against quantum threats [10] - The company is pioneering Post-Quantum Semiconductors designed to protect sensitive data across various applications, ensuring organizations remain secure against quantum threats [12]
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
Globenewswire· 2026-02-27 14:15
Core Insights - Profusa, Inc. has decided not to proceed with a $15 million public offering, as it reassessed its near-term capital needs based on updated revenue projections for 2026 and its collaboration with Mayo Clinic [1][2] - The company plans to pursue a smaller, more focused offering to support projected revenue from its Lumee Oxygen product in Europe starting in Q2 2026 and to invest in its collaboration with Mayo Clinic for U.S. market entry [1][2] Company Overview - Profusa is a commercial stage digital health company based in Berkeley, CA, focused on developing tissue-integrated sensors that provide continuous, actionable medical data [4] - The company aims to deliver long-lasting, injectable biosensors and an intelligent data platform to create personalized biochemical signatures for clinical use [4]
AB Amber Grid Operating Results for the year 2025
Globenewswire· 2026-02-27 14:12
Core Insights - AB Amber Grid reported a significant decline in key financial metrics for the year 2025 compared to 2024, indicating challenges in profitability and revenue generation [1][3]. Financial Performance - EBITDA for 2025 was EUR 17.3 million, down from EUR 26.5 million in 2024 [1]. - Revenue for 2025 was EUR 69.7 million, a decrease from EUR 74.6 million in 2024 [3]. - Net profit for 2025 was EUR 1.4 million, significantly lower than EUR 8.3 million in 2024 [3]. - Adjusted net profit for 2025 was EUR 10.0 million, slightly down from EUR 10.1 million in 2024 [3]. - Adjusted EBITDA remained stable at EUR 27.4 million for both 2025 and 2024 [3]. - Return on equity (ROE) for 2025 was 0.8%, a notable drop from 4.6% in 2024 [1]. Adjusted Financial Indicators - Adjustments to financial indicators were made due to temporary regulatory differences from the profitability approved by the National Energy Regulatory Council (NERC) [1]. - The adjustments included corrections for income from previous periods and deviations between NERC approved and actual profitability for the reporting period [1].
Unaudited financial results of LITGRID AB for the twelve months of 2025
Globenewswire· 2026-02-27 14:05
Core Viewpoint - LITGRID AB reported its financial results for 2025, showing a mixed performance with increased revenue but decreased net profit and EBITDA compared to 2024 [1]. Financial Performance Summary - Revenue for 2025 reached EUR 431.1 million, up from EUR 378.3 million in 2024, reflecting a growth of approximately 14.0% [1]. - EBITDA decreased to EUR 48.9 million in 2025 from EUR 60.5 million in 2024, representing a decline of about 19.5% [1]. - Net profit fell to EUR 34.2 million in 2025, down from EUR 49.0 million in 2024, indicating a decrease of approximately 30.4% [1]. - Return on Equity (ROE) decreased to 13.0% in 2025 from 19.7% in 2024 [1]. - Adjusted EBITDA improved to EUR 53 million in 2025 from EUR 47.6 million in 2024, showing an increase of about 11.1% [1]. - Adjusted net profit rose to EUR 37.7 million in 2025, compared to EUR 34.3 million in 2024, marking an increase of approximately 10.0% [1]. - Adjusted ROE increased to 14.3% in 2025 from 13.8% in 2024 [1].
Unaudited financial results of VILVI Group for the 12 months of 2025
Globenewswire· 2026-02-27 14:05
Core Insights - VILVI Group reported a consolidated sales revenue of EUR 286.9 million for the 12 months of 2025, reflecting a 16.9% increase compared to EUR 245.4 million in 2024 [1] - The Group's net profit for 2025 was EUR 10.39 million, which represents a significant decrease of 59.9% from the previous year's profit [1] Financial Performance - Consolidated sales revenue for 2025: EUR 286.9 million, up 16.9% from 2024's EUR 245.4 million [1] - Net profit for 2025: EUR 10.39 million, down 59.9% compared to 2024 [1]
Boralex Announces the Appointment of Philippe Bonin as Chief Financial Officer
Globenewswire· 2026-02-27 14:00
Philippe Bonin Photo of Philippe Bonin. MONTREAL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) is pleased to announce the appointment of Philippe Bonin as Executive Vice President and Chief Financial Officer, effective March 16, 2026. In this role, Mr. Bonin will bring his extensive experience to support the delivery of the 2030 Strategic Plan. Mr. Bonin’s appointment follows a rigorous selection process. Stéphane Milot, who has served as Interim Chief Financial ...
Renforth Advancing Work on Globex’s Parbec Gold Royalty Property
Globenewswire· 2026-02-27 14:00
TORONTO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to provide an update on work by Renforth Resources Inc. (RFR-CSE, RFHRF-OTC, 9RR-FSE) on Globex’s Parbec gold royalty property located in Malartic township, Quebec. The property straddles the gold localizing C ...
AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering
Globenewswire· 2026-02-27 14:00
OCALA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of its lead product, Ampligen® (rintatolimod), for the treatment of late-stage pancreatic cancer – a lethal and unmet global health problem – today announced updated terms for its previously announced rights offering (the “Rights Offering”). Each subscription right now entitles holders to purchase one unit (th ...